Skip to main content
. 2023 Dec 20;19(Suppl 1):106. doi: 10.1186/s13223-023-00845-9

Table 1 (abstract O-28).

Laboratory study at diagnosis

Patient number Plasma C1-INH function (> 50%) Antigenic C1-INH (16.0–33.0 mg/dL) Serum C4 levels (14.0–60.0 mg/dL) Serum C1q levels (> 100 µg/dL) Autoantibodies anti C1INH (antiC1INHAbs) Immunocomplexes C1INH–antiC1INHAb SERPING1 gene study
1 50 4.8 1.67 60 ND ND ND
2 10.4 27.5 7.71 60 ND ND ND
3 11 9.8 138 ND ND ND
4 40 9.89 2 58 Negative ND ND
5 18 2.8 1.4 11.5 IgG ND ND
6 14.06 17.9 16.4 120 Negative ND Negative
7 25.67 16.2 157.95 IgG ND Negative
8 6 15 1.56 0 IgA Negative Negative
9 10.77 5.82 1.56 0 IgA, IgG ND Negative
10 21.61 13 35.9 233.16 Negative* Negative* Negative
11 33.46 12.1 1.66 32.13 Negative IgG Negative
12 19.64 4.62 5.32 111.88 IgA, IgM Negative Negative
13 25.96 3.99 1.5 71.82 Negative IgA, IgG Negative
14 11.38 5.49 3.53 58.11 IgM Negative Negative
15 7.9 5.24 ND 115.58 IgG Negative Negative

ND: Not done.

*Patient 10 had positive autoC1-INHabs several years later.